Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

India · Delayed Price · Currency is INR

1,758.80

-5.20 (-0.29%)

Oct 16, 2026, 3:29 PM IST

Revenue

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
India Formulations Revenue	200.44B	192.90B	169.23B
US Formulations Revenue	168.21B	168.24B	162.40B
Emerging Markets Revenue	115.79B	111.86B	94.16B
Rest of the World Formulations Revenue	87.63B	85.68B	71.63B
Total Formulations Revenue	572.07B	558.69B	497.42B
Active Pharmaceutical Ingredients (API) Revenue	22.42B	21.85B	21.29B
Other Segment Revenue	1.68B	1.65B	1.70B
Other Operating Revenue	2.93B	2.42B	5.37B

Key Performance Indicators

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Number of Medical Representatives	16.77K	15.11K
Sales per Medical Representative	11.50M	11.20M